Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CRISTINA J RAMOS

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1447370523
CMS profile
291972
Location
SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$25,865.56

74 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–74 of 74 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CRISTINA J RAMOS

NPI 1447370523 · CMS profile ID 291972

Allopathic & Osteopathic Physicians / Allergy & Immunology

SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–74 of 74 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447370523?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CRISTINA J RAMOS, NPI 1447370523, CMS profile ID 291972. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–74 of 74 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447370523?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CRISTINA J RAMOS, NPI 1447370523, CMS profile ID 291972. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–74 of 74 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447370523?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CRISTINA J RAMOS, NPI 1447370523, CMS profile ID 291972, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–74 of 74 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1447370523?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

74 matching records · $25,865.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 74 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–74 of 74.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $1,395.0007/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820172551 CMS
PFIZER INC. $34.9507/06/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832796983 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.9507/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820172545 CMS
GENZYME CORPORATION $24.9506/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641389 CMS
GENZYME CORPORATION $1,401.0006/25/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641415 CMS
GENZYME CORPORATION $11.2606/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641385 CMS
BioCryst US Sales Co., LLC $13.7005/18/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849112277 CMS
PBG PUERTO RICO LLC $16.5905/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832809459 CMS
GlaxoSmithKline, LLC. $6.3004/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802390735 CMS
PFIZER INC. $1,525.0004/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833400585 CMS
AstraZeneca Pharmaceuticals LP $14.9504/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829832083 CMS
AstraZeneca Pharmaceuticals LP $14.9503/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829429749 CMS
GlaxoSmithKline, LLC. $69.9903/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802815953 CMS
Takeda Pharmaceuticals U.S.A., Inc. $450.0003/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820172539 CMS
GENZYME CORPORATION $25.0003/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641365 CMS
GENZYME CORPORATION $13.8003/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641357 CMS
Takeda Pharmaceuticals U.S.A., Inc. $337.5003/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820172533 CMS
GlaxoSmithKline, LLC. $23.9703/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803091547 CMS
Takeda Pharmaceuticals U.S.A., Inc. $900.0002/24/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820172527 CMS
AstraZeneca Pharmaceuticals LP $14.9502/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830027425 CMS
GENZYME CORPORATION $4.8402/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843641347 CMS
PBG PUERTO RICO LLC $18.1902/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832788097 CMS
GlaxoSmithKline, LLC. $15.5602/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802850237 CMS
AstraZeneca Pharmaceuticals LP $14.9901/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829396571 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $32,790.60 81
PY2020 $14,930.12 40
PY2021 $25,865.56 74
PY2022 $79,578.36 131
PY2023 $87,976.49 151
PY2024 $81,435.13 125
PY2025 $118,116.34 131

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $29,501.35 61
PY2024 Recipient $1,495.70 10
PY2024 Principal investigator $43,375.41 55
PY2023 Principal investigator $15,081.73 8
PY2022 Principal investigator $26,031.77 11
PY2021 Principal investigator $15,446.59 7

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

61 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 12/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184274973
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,200.00 12/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184274975
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $750.00 12/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184274979
Principal investigator 1 Novartis Pharmaceuticals Corporation $22.58 11/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of Remibrutinib (LOU064) to Investigate the Efficacy, Safety and Tolerability for 52 Weeks in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1-antihi No dispute reported 06/30/2026 1190302761
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259203
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259205
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259207
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259209
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259211
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259213
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259215
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259217
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259219
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259221
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259223
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259225
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259227
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $81.25 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259229
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 11/10/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184259231
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,000.00 08/07/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184225993
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 08/07/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184225995
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,500.00 08/07/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184225997
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $12,000.00 08/07/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184225999
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,041.00 08/07/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184226001
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $550.00 05/01/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184191617
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $550.00 05/01/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184191619
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $447.28 04/28/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190299
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $447.28 04/28/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190301
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $447.28 04/28/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190303
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $447.28 04/28/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190305
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 03/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184173604
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 03/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184173606
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 03/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184173608
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 03/12/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184173610
Principal investigator 1 GENZYME CORPORATION $1,325.00 02/10/2025 Non-covered Recipient Entity
Fundacion De Investigacion De Diego Inc Dba Fdi Clinical Research
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma No dispute reported 06/30/2026 1226114745
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/17/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148503
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/17/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148505
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/17/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148507
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148027
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $81.25 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148029
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148031
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148033
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $81.25 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148035
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148037
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/16/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184148039
Principal investigator 1 Novartis Pharmaceuticals Corporation $112.90 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of Remibrutinib (LOU064) to Investigate the Efficacy, Safety and Tolerability for 52 Weeks in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1-antihi No dispute reported 06/30/2026 1190302763
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147881
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147883
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147885
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147887
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $81.25 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147889
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $40.30 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147891
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147893
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $81.25 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147895
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147897
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147899
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147901
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $195.00 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147903
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147905
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $18.20 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147907
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/15/2025 Non-covered Recipient Entity
FUNDACION DE INVESTIGACION DE DIEGO
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184147909